Current Enzyme Inhibition

Editor-in-Chief

Claudiu T. Supuran
(83932 citations)
University of Florence
Florence
(Italy)

Personal Subscription
Become EABM
Become Reviewer

Editorial promotion: free to download

Volume:9   Issue: 2
Pp: i-i
D. Hadjipavlou-Litina
DOI: 10.2174/1573408011309020001

Tacrolimus Toxicity Reverses the Inhibitory Effects of Renin Angiotensin System Blockade on PAI-1 Expression in Cardiac Tissue

Volume:9   Issue: 2
Pp: 83-88
Mehmet Agirbasli, Emine Bas Bozkurtlar, Nurdan Papila-Topal, Hicran Deniz, Betul Ogutmen and Fulya Cakalagaoglu
DOI: 10.2174/1573408011309020002

Targeting Lipoxygenases (LOs): Drug Design And Discovery

Volume:9   Issue: 2
Pp: 89-105
Eleni Pontiki and Dimitra Hadjipavlou–Litina
DOI: 10.2174/1573408011309020003

Advances in Design and Development of Inhibitors of Nitric Oxide Synthases

Volume:9   Issue: 2
Pp: 117-141
Harish Kumar, Satya P. Gupta, Anees A. Siddiqui and Vijay Kumar
DOI: 10.2174/1573408011309020005

Targeting Metabolic Enzymes in Cancer – Clinical Trials Update

Volume:9   Issue: 2
Pp: 152-160
Julie O’Neal and Jason Chesney
DOI: 10.2174/1573408011309020007

The Proteasome as a Therapeutic Target for Lung Fibrosis

Volume:9   Issue: 2
Pp: 161-167
Leonard H.T. Go, Jinal K. Gangar and Manu Jain
DOI: 10.2174/1573408011309020008

Acknowledgements to Reviewers promotion: free to download

Volume:9   Issue: 2
Pp: 168-168

DOI: 10.2174/1573408011309020009